The first stop for professional medicines advice

Medicines planning

39 results

Applied filters

Good governance when implementing ranibizumab biosimilar

29 June 2022Governance should consider processes for approval; procurement and supply; prescribing and administration; monitoring; and pharmacovigilance

The licence and supporting evidence for ranibizumab biosimilars

29 June 2022Four licensed ranibizumab biosimilars are available: Byooviz, Ongavia, Rimmyrah and Ximluci. Learn about the licensed indications and supporting evidence

Understanding biological and biosimilar medicines

29 June 2022Biosimilar medicines are a type of biological medicine that offer the NHS opportunities to deliver better value for certain conditions

Annual medicines planning

Our annual Prescribing Outlook outputs support planning, implementation and budget planning for medicines every year.

Biosimilars

Regularly updated material to support the introduction of eculizumab, natalizumab, ranibizumab, tocilizumab and ustekinumab biosimilars.

Planning

We support organisations with the planned introduction of medicines. We create annual review products as well as ongoing updates to keep you informed.

National Homecare Medicines Committee (NHMC) Engagement with Manufacturers Advice

4 August 2020The National Pharmaceutical Supply Group (NPSG) currently advises against participation in advisory boards sponsored by Manufacturers (Marketing Authorisation Holders). This NHMC paper supports this advice…

National Homecare Medicines Committee (NHMC) Homecare Digital Strategy

4 August 2020This is the NHMC and NCHA joint digital strategy and roadmap for the next 5 years. It sets out a direction of travel for homecare…
Registration required

Lists of new product launches

11 February 2020Annual lists of new products and formulations that have launched, and had licence changes approved. Usually published each February.

National Homecare Medicines Committee (NHMC) Homecare Risk Assessment

10 December 2019To support organisations in establishing a robust risk assessment process for new homecare medicines services the NHMC has developed a tool for local use.  …